| Financial Year |
March 31 2023 |
| Monetary Funds |
366,877,455.30 |
| Held-for-trading Financial Assets |
16,592,196.15 |
| Notes Receivable |
-- |
| Accounts Receivable |
270,002,220.98 |
| Advances to Suppliers |
17,884,119.40 |
| Other Receivables |
1,808,620.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
369,651,365.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
212,707,037.87 |
| Total Current Assets |
1,265,473,750.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
12,734,215.73 |
| Fixed Assetes |
727,065,005.25 |
| Under-construction Projects |
77,728,085.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,454,489.28 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,066,355.23 |
| Deferred Income Tax Assets |
23,913,334.50 |
| Other Non-Current Assets |
124,331,079.16 |
| Sub-Total of Non-Current Assets |
1,165,660,297.84 |
| Total Assets |
2,431,134,048.23 |
| Short-Term Loans |
456,182,748.49 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,025,889.09 |
| Accounts Payable |
219,478,510.08 |
| Accounts Received In Advance |
54,275.00 |
| Employee Compensation Payable |
21,513,842.12 |
| Taxes Payable |
5,823,673.04 |
| Interest Payable |
-- |
| Dividend Payable |
11,200,000.00 |
| Other payables |
21,136,147.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,427,879.31 |
| Other Current Liabilities |
1,214,556.11 |
| Sub-Total of Current Liabilities |
767,567,774.32 |
| Long-term Loans |
120,400,000.00 |
| Bonds Payable |
212,177,380.64 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,778,901.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
403,442,733.41 |
| Total Liabilities |
1,171,010,507.73 |
| Paid-In Capital(Or Share Stock) |
131,643,847.00 |
| Capital Surplus |
795,078,521.61 |
| Surplus Reserve |
32,644,059.29 |
| LESS:Treasury Stock |
65,332,655.47 |
| Undistributed Profits |
239,139,616.49 |
| Minority Stockholder's Interest |
34,427,778.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,225,695,762.20 |
| Owner's Equity（Stockholder's Equity） |
1,260,123,540.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,431,134,048.23 |
